Cytospire Therapeutics CEO Natalie Mount receives dual recognition for leadership in life sciences
Cytospire Therapeutics CEO Natalie Mount receives dual recognition for leadership in life sciences
Cytospire Therapeutics is proud to announce that its Co-Founder and CEO, Natalie Mount, has been named one of 2026's Fiercest Women in Life Sciences by Fierce Biotech and has won the European Lifestars Award for Women-Led Business of the Year.
Published today, Fierce's annual list celebrates women making a meaningful impact across the life sciences sector, recognising leaders with strong career track records in mentorship, leadership and scientific innovation.
The European Lifestars Awards celebrate the achievements of European life science executives and their partners. The Women-Led Business of the Year award recognises female founders and management executives who have demonstrated superior leadership, vision and inspiration, or delivered transformational outcomes for their business and the wider sector.
Natalie has spent her career translating pioneering science into new therapeutic approaches. Her experience spans drug development, cell and gene therapy and immuno-oncology.
Before co-founding Cytospire, Natalie was CEO of Adaptate Biotherapeutics and previously CSO of Gamma Delta Therapeutics, two companies focused on harnessing gamma delta T cells for cancer treatment. She was also part of the founding team at the Cell and Gene Therapy Catapult, serving as Chief Clinical Officer, following an earlier career at Pfizer.
These latest accolades follow further recent recognition of Natalie's contribution to biotechnology and translational science. She was named Woman Entrepreneur of the Year at the 2025 Cancer Research Horizons Innovation and Entrepreneurship Awards and, earlier this year, was elected a Fellow of the Academy of Medical Sciences.
Today, Natalie leads Cytospire as the company advances a portfolio of differentiated multispecific immune cell engager antibodies designed to enhance and direct the activity of the body's own immune system to improve outcomes for cancer patients.
Natalie Mount, Co-Founder and CEO of Cytospire Therapeutics, commented:
"I'm honoured to receive these recognitions. I've always believed the strongest science comes from bringing talented people together around an ambitious goal. I see that every day at Cytospire, and I'm incredibly proud of our team and what we're building together."
Read Natalie's Fierce profile and the full 2026 Fiercest Women in Life Sciences list here.
